CD44 and head and neck squamous cell carcinoma: Elkashty et al. combined the positivity of CD44 to CD271 (p75NTR), a described marker of CSC in many tumors[117], to isolate an enriched subpopulation of CSCs, followed by their characterization in vitro, in vivo, and HNSCC tissue samples.